Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver.

Journal of the American Heart Association

Volumn 2, Issue 2, 2013, Pages

  Liu, Yan ^a   Major, Amy S ^b   Zienkiewicz, Jozef ^b   Gabriel, Curtis L ^b   Veach, Ruth Ann ^b   Moore, Daniel J ^b   Collins, Robert D ^b   Hawiger, Jacek ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; CHOLESTEROL; CSN50.1 PEPTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEPTIDE; SN 50; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ACTIVE TRANSPORT; ANIMAL; ARTICLE; ATHEROSCLEROSIS; CELL NUCLEUS; DISEASE MODEL; DRUG EFFECT; FAT INTAKE; FATTY LIVER; FEMALE; HYPERCHOLESTEROLEMIA; LIVER; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ATHEROSCLEROSIS; CELL NUCLEUS; CELL-PENETRATING PEPTIDES; CHOLESTEROL; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; HYPERCHOLESTEROLEMIA; LIVER; MICE; MICE, TRANSGENIC; NF-KAPPA B; PEPTIDES; STEROL REGULATORY ELEMENT BINDING PROTEINS; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 84884364399     PISSN: None     EISSN: 20479980     Source Type: None    
DOI: 10.1161/JAHA.113.000093     Document Type: Article

References (0)